Psychotropic Drugs Show Anticancer Activity by Disrupting Mitochondrial and Lysosomal Function
Background and Purpose: Drug repositioning is a promising strategy for discovering new therapeutic strategies for cancer therapy. We investigated psychotropic drugs for their antitumor activity because of several epidemiological studies reporting lower cancer incidence in individuals receiving long...
Main Authors: | Marco Varalda, Annamaria Antona, Valentina Bettio, Konkonika Roy, Ajay Vachamaram, Vaibhav Yellenki, Alberto Massarotti, Gianluca Baldanzi, Daniela Capello |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.562196/full |
Similar Items
-
Toward fully exploiting the therapeutic potential of marketed pharmaceuticals: the use of octreotide and chloroquine in oncology
by: Papanagnou P, et al.
Published: (2018-12-01) -
Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
by: Ulf Norinder, et al.
Published: (2020-10-01) -
The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane
by: Michal Stark, et al.
Published: (2020-04-01) -
Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification
by: Edward C Lauterbach
Published: (2016-01-01) -
Novel Approaches of Dysregulating Lysosome Functions in Cancer Cells by Specific Drugs and Its Nanoformulations: A Smart Approach of Modern Therapeutics
by: Allemailem KS, et al.
Published: (2021-07-01)